#desci
desci
433,052 views
810 Discussing
Hot
Latest
For decades, human innovation has been held hostage by a deeply parasitic, centralized academic cartel.
If a brilliant researcher wants to cure a disease, they are forced to spend half their time begging legacy institutions for grants. When they finally publish, a massive publishing monopoly takes their work for free, forces other scientists to peer-review it for free, and then charges the public astronomical fees just to read the results. Intellectual property is locked away in corporate silos, severely bottlenecking global scientific progress.
Decentralized Science (DeSci) is systematically destroying this outdated bottleneck.
By moving scientific intellectual property on-chain as IP-NFTs, researchers can now directly crowdsource funding from global decentralized autonomous organizations (DAOs). Peer review is financially incentivized through tokenized rewards, and the underlying research data is stored permanently on decentralized networks, accessible to anyone.
We are actively shifting from closed, proprietary research to an open-source, programmable scientific economy. The protocols building this decentralized research infrastructure are not just disrupting academic publishing; they are fundamentally accelerating the pace of human discovery.
$ATH $BIO $RIF
#Write2Earn #DeSci
If a brilliant researcher wants to cure a disease, they are forced to spend half their time begging legacy institutions for grants. When they finally publish, a massive publishing monopoly takes their work for free, forces other scientists to peer-review it for free, and then charges the public astronomical fees just to read the results. Intellectual property is locked away in corporate silos, severely bottlenecking global scientific progress.
Decentralized Science (DeSci) is systematically destroying this outdated bottleneck.
By moving scientific intellectual property on-chain as IP-NFTs, researchers can now directly crowdsource funding from global decentralized autonomous organizations (DAOs). Peer review is financially incentivized through tokenized rewards, and the underlying research data is stored permanently on decentralized networks, accessible to anyone.
We are actively shifting from closed, proprietary research to an open-source, programmable scientific economy. The protocols building this decentralized research infrastructure are not just disrupting academic publishing; they are fundamentally accelerating the pace of human discovery.
$ATH $BIO $RIF
#Write2Earn #DeSci
🔥 $AIGENSYN This wave didn’t disappoint! In the past 24 hours, it surged 4.1% and the trading value straight-up hit $27 million. The volume-expansion breakout signal is already flashing. RSI 52—neither hot nor cold, just right. The uptrend is steadily holding, and the 5% amplitude suggests the main players are still shaking the market to accumulate. Next, it’s very likely to accelerate.
The AI + synthetic biology track has been insanely hot lately. With $AIGENSYN as the leading stock, you can clearly see how much attention the capital is paying. At this point, you can go on the offensive and still have room to retreat—don’t wait until it flies and then regret it.
What do you think? Let’s chat in the comments 👇
$AIGENSYN #AI #DeSci
The AI + synthetic biology track has been insanely hot lately. With $AIGENSYN as the leading stock, you can clearly see how much attention the capital is paying. At this point, you can go on the offensive and still have room to retreat—don’t wait until it flies and then regret it.
What do you think? Let’s chat in the comments 👇
$AIGENSYN #AI #DeSci
Verified
This time, I was checking the market when an asset suddenly appeared on my screen.
$LAB had risen by more than 140%.
It wasn’t the first time I’d seen a move like that.
But I asked a different question:
—What does this project really do?
After looking a bit, I discovered something curious.
Many people believe that the future of biotechnology and artificial intelligence will depend solely on having smarter models.
But there’s another, much harder problem:
How do you share scientific data, discoveries, or research without losing control over it?
That’s where I came across the idea behind Bio Protocol and the $LAB ecosystem.
The proposal revolves around something interesting:
creating communities capable of funding, coordinating, and accelerating scientific research using blockchain and digital ownership mechanisms.
In other words, trying to make scientific innovation not depend only on a few institutions, but so that more people can participate in its development.
Maybe that’s why $LAB has started to draw the market’s attention.
Because behind the price movement there’s a much bigger question:
If artificial intelligence and biotechnology are going to transform the future, who will take part in building those discoveries—and who will benefit from them?
@BIO Protocol
#BioProtocol #DeSci #AI #Nomadacripto #Web3
$LAB
$LAB had risen by more than 140%.
It wasn’t the first time I’d seen a move like that.
But I asked a different question:
—What does this project really do?
After looking a bit, I discovered something curious.
Many people believe that the future of biotechnology and artificial intelligence will depend solely on having smarter models.
But there’s another, much harder problem:
How do you share scientific data, discoveries, or research without losing control over it?
That’s where I came across the idea behind Bio Protocol and the $LAB ecosystem.
The proposal revolves around something interesting:
creating communities capable of funding, coordinating, and accelerating scientific research using blockchain and digital ownership mechanisms.
In other words, trying to make scientific innovation not depend only on a few institutions, but so that more people can participate in its development.
Maybe that’s why $LAB has started to draw the market’s attention.
Because behind the price movement there’s a much bigger question:
If artificial intelligence and biotechnology are going to transform the future, who will take part in building those discoveries—and who will benefit from them?
@BIO Protocol
#BioProtocol #DeSci #AI #Nomadacripto #Web3
$LAB
caimán2025:
verdad eso
$BIO IS BUILDING A FOUNDATION FOR THE DESCI NARRATIVE IN 2028 🔥
BIO is displaying classic accumulation structure on the daily chart — grinding higher with a three-steps-forward-two-steps-back rhythm. This behavior suggests smart money is systematically building positions at these lows.
DeSci remains in its infancy while AI dominates headlines. As the clear leader in this niche, BIO could mature into a major cycle driver. Market cap is still small, leaving room for significant upside potential.
The daily candle is just starting to lift from the base — are you positioning ahead of the crowd or waiting for confirmation?
Not financial advice. Always manage your risk.
#BIO #DeSci #CryptoAccumulation #LongTermSetup
💎
BIO is displaying classic accumulation structure on the daily chart — grinding higher with a three-steps-forward-two-steps-back rhythm. This behavior suggests smart money is systematically building positions at these lows.
DeSci remains in its infancy while AI dominates headlines. As the clear leader in this niche, BIO could mature into a major cycle driver. Market cap is still small, leaving room for significant upside potential.
The daily candle is just starting to lift from the base — are you positioning ahead of the crowd or waiting for confirmation?
Not financial advice. Always manage your risk.
#BIO #DeSci #CryptoAccumulation #LongTermSetup
💎
$BIO Recently, the market has clearly turned much hotter: open interest surged 9.1% in a single day, while the price rose 6.5% over the past 24 hours—bullish sentiment is starting to return.
The driving logic is actually quite straightforward—OpenLabs has launched a USDC yield mechanism, injecting a new path for capital to remain within the ecosystem; meanwhile, the “AI + biotech” narrative has continued to intensify recently. As a core asset in this sector, Bio Protocol naturally draws increased attention from investors.
Current price is $0.02985, with a market cap of about $66.48 million. 24h trading volume is $23.33 million, and the turnover activity looks quite strong. In the short term, with both derivatives-side capital inflows and a narrative catalyst aligning, it may sustain a pulse-like rebound. However, the market cap size is relatively small, so volatility will be amplified—when chasing higher prices, be sure to watch the risk of liquidation from leveraged positions.
Personal view: follow the trend with a small position size, and set your stop-loss below the breakout/volume-expansion trigger point—this is generally more cost-effective than chasing the top. For narrative coins, the rhythm is always: “trust the money flow, not the hype.”
#BioProtocol #DeSci #AI
The driving logic is actually quite straightforward—OpenLabs has launched a USDC yield mechanism, injecting a new path for capital to remain within the ecosystem; meanwhile, the “AI + biotech” narrative has continued to intensify recently. As a core asset in this sector, Bio Protocol naturally draws increased attention from investors.
Current price is $0.02985, with a market cap of about $66.48 million. 24h trading volume is $23.33 million, and the turnover activity looks quite strong. In the short term, with both derivatives-side capital inflows and a narrative catalyst aligning, it may sustain a pulse-like rebound. However, the market cap size is relatively small, so volatility will be amplified—when chasing higher prices, be sure to watch the risk of liquidation from leveraged positions.
Personal view: follow the trend with a small position size, and set your stop-loss below the breakout/volume-expansion trigger point—this is generally more cost-effective than chasing the top. For narrative coins, the rhythm is always: “trust the money flow, not the hype.”
#BioProtocol #DeSci #AI
Recently, the market action for <t-2/> has been a bit interesting: over the past 24 hours, it’s up 6.5%. Open interest has increased by 9.1%, and short-term capital has clearly started moving in.
Behind this are two catalysts: first, OpenLabs has introduced a USDC yield mechanism, injecting a new logic for how capital is retained within the protocol. Second, the AI + biotech narrative has seen renewed momentum recently, and the market is willing to re-price this kind of project with a premium.
Current price is $0.02985, market cap is $66.48M, and trading volume is $23.33M. The circulating supply isn’t large—once sentiment catches fire, volatility tends to get amplified. In the short term, I’m more focused on whether contract positions can continue to move up along with price. If OI falls while price lags upward, then you should be cautious about pullbacks after long squeezes.
When you have both narrative and funding driving the move, it’s easy to act impulsively—position management is worth more than direction-guessing.
#BIO #DeSci #AI $BIO
Behind this are two catalysts: first, OpenLabs has introduced a USDC yield mechanism, injecting a new logic for how capital is retained within the protocol. Second, the AI + biotech narrative has seen renewed momentum recently, and the market is willing to re-price this kind of project with a premium.
Current price is $0.02985, market cap is $66.48M, and trading volume is $23.33M. The circulating supply isn’t large—once sentiment catches fire, volatility tends to get amplified. In the short term, I’m more focused on whether contract positions can continue to move up along with price. If OI falls while price lags upward, then you should be cautious about pullbacks after long squeezes.
When you have both narrative and funding driving the move, it’s easy to act impulsively—position management is worth more than direction-guessing.
#BIO #DeSci #AI $BIO
BIO's short-term momentum is building. Open interest surged 9.1% over the past 24 hours, while the price rose in tandem by 6.5%. This kind of volume-and-price rising combination often suggests that capital is positioning in advance.
There are two main driving lines of logic: first, the USDC yield mechanism introduced by OpenLabs, which gives holders a new entry point for capital efficiency; second, the narrative of AI + biotech, whose popularity has continued to climb this year. $BIO , as a representative target for the sector, naturally absorbs spillover sentiment.
Current price is $0.02985, market cap is $66.48M, and 24-hour trading volume is $23.33M. Turnover activity has already reached a healthy level. In the short term, I’m more focused on whether open positions at the time of the opening can continue to expand—if long positions keep stacking up, this upswing may develop into a structural trend; otherwise, be cautious of profit-taking pullbacks.
A window where narrative + mechanism + capital all resonate together isn’t that common, and it’s worth adding to your watchlist.
#BIO #DeSci #AI
There are two main driving lines of logic: first, the USDC yield mechanism introduced by OpenLabs, which gives holders a new entry point for capital efficiency; second, the narrative of AI + biotech, whose popularity has continued to climb this year. $BIO , as a representative target for the sector, naturally absorbs spillover sentiment.
Current price is $0.02985, market cap is $66.48M, and 24-hour trading volume is $23.33M. Turnover activity has already reached a healthy level. In the short term, I’m more focused on whether open positions at the time of the opening can continue to expand—if long positions keep stacking up, this upswing may develop into a structural trend; otherwise, be cautious of profit-taking pullbacks.
A window where narrative + mechanism + capital all resonate together isn’t that common, and it’s worth adding to your watchlist.
#BIO #DeSci #AI
BIO: This recent wave of unusual activity is worth paying attention to. Open interest jumped 9.1% in a single day, while price rose 6.5% in tandem—short-term capital has clearly moved in.
The driving forces mainly come from two lines: first, OpenLabs introduced a USDC yield mechanism, bringing a tangible expectation of liquidity being locked in on the protocol; second, the narrative of AI + biotech continues to ferment in the market, and the DeSci sector is regaining attention.
The current quote is $BIO at $0.02985, market cap is about $66.48 million, 24-hour trading volume is $23.33 million, and liquidity looks healthy for this size. Both futures open positions and spot trading have expanded simultaneously, forming a relatively clean upward structure. However, because the market cap is still small, pullbacks may be more severe—position management matters more than chasing the price.
In the short term, we need to see whether the narrative can continue. In the medium term, the key will be the actual performance data of OpenLabs’ yield product.
#BIO #DeSci #AI
The driving forces mainly come from two lines: first, OpenLabs introduced a USDC yield mechanism, bringing a tangible expectation of liquidity being locked in on the protocol; second, the narrative of AI + biotech continues to ferment in the market, and the DeSci sector is regaining attention.
The current quote is $BIO at $0.02985, market cap is about $66.48 million, 24-hour trading volume is $23.33 million, and liquidity looks healthy for this size. Both futures open positions and spot trading have expanded simultaneously, forming a relatively clean upward structure. However, because the market cap is still small, pullbacks may be more severe—position management matters more than chasing the price.
In the short term, we need to see whether the narrative can continue. In the medium term, the key will be the actual performance data of OpenLabs’ yield product.
#BIO #DeSci #AI
BIO has recently shown clear signs of an active trading market; open interest has surged 9.1% and the price is up 6.5% over the past 24 hours, igniting short-term sentiment.
There are two key drivers: first, OpenLabs has introduced a USDC yield mechanism, injecting expectations of real cash flow into the ecosystem; second, the “AI + biotech” narrative continues to heat up, prompting capital to start reassessing this once-overlooked sector.
Current price is $0.02985, with a market cap of only $66.48 million. The 24-hour trading volume is 23.33 million, and turnover activity is not low. This combination of small market cap, narrative catalyst, and leveraged positions does make it easier for short-term volatility to emerge—but investors should also be wary of the risk of pullbacks after sentiment cools.
The focus is whether actual adoption data for the USDC mechanism can keep pace; narrative alone can’t last for too long.
$BIO #DeSci #AI+biotechnology
There are two key drivers: first, OpenLabs has introduced a USDC yield mechanism, injecting expectations of real cash flow into the ecosystem; second, the “AI + biotech” narrative continues to heat up, prompting capital to start reassessing this once-overlooked sector.
Current price is $0.02985, with a market cap of only $66.48 million. The 24-hour trading volume is 23.33 million, and turnover activity is not low. This combination of small market cap, narrative catalyst, and leveraged positions does make it easier for short-term volatility to emerge—but investors should also be wary of the risk of pullbacks after sentiment cools.
The focus is whether actual adoption data for the USDC mechanism can keep pace; narrative alone can’t last for too long.
$BIO #DeSci #AI+biotechnology
📉 Bio Protocol ($BIO ) is going through a clearly noticeable “quiet spell”
At the DeSci Berlin conference, the OpenLabs platform was announced—this was good news in principle—but the community’s attention was almost entirely drawn away by other AI and biotech projects, and $BIO was all but ignored.
The result of low trading volume and lack of media hype is that the price has been under continuous pressure.
Current price 0.0289 USDT
24h trading volume 33.22M
Market cap 64.14M
Before this track truly takes off, being undervalued ≠ having no value. In quiet periods, sometimes it’s exactly the right time to take a second look.
#DeSci #BIO
At the DeSci Berlin conference, the OpenLabs platform was announced—this was good news in principle—but the community’s attention was almost entirely drawn away by other AI and biotech projects, and $BIO was all but ignored.
The result of low trading volume and lack of media hype is that the price has been under continuous pressure.
Current price 0.0289 USDT
24h trading volume 33.22M
Market cap 64.14M
Before this track truly takes off, being undervalued ≠ having no value. In quiet periods, sometimes it’s exactly the right time to take a second look.
#DeSci #BIO
$BIO recent market performance has been rather lackluster. In the current cycle of narratives, it has temporarily slipped out of the mainstream view. At the DeSci Berlin Conference, the release of the OpenLabs platform brought only sporadic community mentions, without triggering any notable increase in trading volume or media attention. When the community’s focus is entirely captured by popular biotech and AI projects, projects that lack fresh narratives naturally face selling pressure.
That said, looking from another angle: a 24-hour trading volume of 33.18 million, a market cap of 64.11 million, and a price of $0.0289 are actually not too bad given the current market environment. The DeSci track’s narrative hasn’t fully taken off yet—maybe this quiet period is a good time to set up a position?
#DeSci #BioProtocol
That said, looking from another angle: a 24-hour trading volume of 33.18 million, a market cap of 64.11 million, and a price of $0.0289 are actually not too bad given the current market environment. The DeSci track’s narrative hasn’t fully taken off yet—maybe this quiet period is a good time to set up a position?
#DeSci #BioProtocol
DeSci OpenLabs platform was released at the Berlin conference, but it failed to generate the expected market response for $BIO .
The funding siphon effect in the biotech and AI sectors is becoming increasingly apparent; community discussions have generally shifted, and Bio Protocol can only attract occasional attention. Trading volume has not seen any effective expansion, and media coverage remains relatively low. This lack of mainstream capital attention will indeed exert some downward pressure on short-term prices.
The current market cap of Bio Protocol is approximately $64.11 million, with a 24-hour trading volume of $33.18 million and a price of $0.0289. For DeSci projects, beyond technological implementation, how to continuously capture market attention is also an important issue that needs to be addressed.
#DeSci #BioProtocol
The funding siphon effect in the biotech and AI sectors is becoming increasingly apparent; community discussions have generally shifted, and Bio Protocol can only attract occasional attention. Trading volume has not seen any effective expansion, and media coverage remains relatively low. This lack of mainstream capital attention will indeed exert some downward pressure on short-term prices.
The current market cap of Bio Protocol is approximately $64.11 million, with a 24-hour trading volume of $33.18 million and a price of $0.0289. For DeSci projects, beyond technological implementation, how to continuously capture market attention is also an important issue that needs to be addressed.
#DeSci #BioProtocol
The recent heat in the DeSci sector has been fairly visibly split. Various biotech + AI projects take up most of the community’s discussion, and while $BIO (Bio Protocol) announced its OpenLabs platform at the DeSci Berlin conference, it has only received scattered mentions—never really sparking trading momentum or media exposure. At the moment, the $BIO price is around $0.0289, with a 24-hour trading volume of $33.18 million and a market cap of $64.11 million. With market capital attention currently focused on top-tier hot spots, this lack of mainstream interest is very likely to put downward pressure on the price.
#DeSci
#DeSci
📊 Analysis of coin $BIO on the 3-day timeframe
Hey folks, $BIO is at $0.03237, down -4.06%, after a strong pump from $0.0157 to $0.066, and now it's pulling back healthily 👀
Indicators:
Price is below MA(7) and MA(25), the MACD is slightly negative after a positive stretch, and the RSI(24) is at 47, indicating a neutral zone — meaning the market is balanced and needs a clear catalyst for the next move 🧠
Suggested entry: $0.03168 — $0.03237
🎯 Target 1: $0.03658
🎯 Target 2: $0.04828
🎯 Target 3: $0.066
🔴 Stop loss: below $0.02488
About the coin 🧬
BIO or Bio Protocol is a blockchain network specializing in decentralized funding for scientific and biological research (DeSci), connecting researchers with community funding sources and allowing the trading of intellectual property rights for research. Recently, it has become one of the coins labeled as “new narrative assets” in the market alongside TON.
⚠️ The market is balanced — it's best to wait for a clearer signal before jumping in. Trade responsibly and stick to the stop loss. 🛡️
#BIO #DeSci
Hey folks, $BIO is at $0.03237, down -4.06%, after a strong pump from $0.0157 to $0.066, and now it's pulling back healthily 👀
Indicators:
Price is below MA(7) and MA(25), the MACD is slightly negative after a positive stretch, and the RSI(24) is at 47, indicating a neutral zone — meaning the market is balanced and needs a clear catalyst for the next move 🧠
Suggested entry: $0.03168 — $0.03237
🎯 Target 1: $0.03658
🎯 Target 2: $0.04828
🎯 Target 3: $0.066
🔴 Stop loss: below $0.02488
About the coin 🧬
BIO or Bio Protocol is a blockchain network specializing in decentralized funding for scientific and biological research (DeSci), connecting researchers with community funding sources and allowing the trading of intellectual property rights for research. Recently, it has become one of the coins labeled as “new narrative assets” in the market alongside TON.
⚠️ The market is balanced — it's best to wait for a clearer signal before jumping in. Trade responsibly and stick to the stop loss. 🛡️
#BIO #DeSci
Bio Protocol looking to replace the gatekeepers of research funding with AI?
The decentralized science project Bio Protocol has launched an AI research hub, trying to leverage artificial intelligence to determine who gets the research funds. It's a bold move—aiming to lower the barriers and opacity of traditional reviews. But AI can have its biases, and the details are still murky, so let's keep an eye on this before diving in. 🧬🤖 #DeSci #AI
$BIO
The decentralized science project Bio Protocol has launched an AI research hub, trying to leverage artificial intelligence to determine who gets the research funds. It's a bold move—aiming to lower the barriers and opacity of traditional reviews. But AI can have its biases, and the details are still murky, so let's keep an eye on this before diving in. 🧬🤖 #DeSci #AI
$BIO
💲Buy $BIO Win Big Rewards 🎁❓
🧠 SMART MONEY IS QUIETLY ACCUMULATING $BIO ! 🤫🐋
After weeks of quiet consolidation, $BIO (Bio Protocol) is printing a textbook bullish breakout. Volume is surging, and the chart is cleanly locking in higher highs and higher lows. Buyers are completely in control of this DeSci powerhouse!
If the breakout structure holds, we are looking at a major bullish expansion in the coming sessions.
🟢 THE LONG SETUP 🟢
🎯 Entry Zone: 0.0370 – 0.0378
🔴 Stop Loss (SL): 0.0340
💰 TAKE PROFIT TARGETS 💰
🎯 Target 1: 0.0400
🎯 Target 2: 0.0430
🎯 Target 3: 0.0470 🔥
⚠️ Trader Tip: Momentum is incredibly strong right now. Manage your risk, lock in profits as we hit targets, and let the rest ride. Don't sleep on this accumulation phase! 🚀📈
#BIO #DeSci
🧠 SMART MONEY IS QUIETLY ACCUMULATING $BIO ! 🤫🐋
After weeks of quiet consolidation, $BIO (Bio Protocol) is printing a textbook bullish breakout. Volume is surging, and the chart is cleanly locking in higher highs and higher lows. Buyers are completely in control of this DeSci powerhouse!
If the breakout structure holds, we are looking at a major bullish expansion in the coming sessions.
🟢 THE LONG SETUP 🟢
🎯 Entry Zone: 0.0370 – 0.0378
🔴 Stop Loss (SL): 0.0340
💰 TAKE PROFIT TARGETS 💰
🎯 Target 1: 0.0400
🎯 Target 2: 0.0430
🎯 Target 3: 0.0470 🔥
⚠️ Trader Tip: Momentum is incredibly strong right now. Manage your risk, lock in profits as we hit targets, and let the rest ride. Don't sleep on this accumulation phase! 🚀📈
#BIO #DeSci
The $BIO o Protocol price has gone up a , over 11 percent in the 24 hours. It is now over $0.0360. The Bio Protocol trading volume is really high it is over $138 million. This is interesting because the rest of the crypto market is not doing well.
The $BIO o Protocol is doing well because some rich people are putting a lot of money into it. This is making more people want to buy the Bio Protocol. The Bio Protocol is also useful for something called Decentralized Science. This is making people want to buy it more.
It is easier to buy and sell the Bio Protocol now because it is available on trading platforms. This is why the Bio Protocol price is changing a lot. If the Bio Protocol price stays above $0.035 it might keep going up. It could even reach $0.040.. If it falls below $0.035 it could go down to $0.032.
The $Bio Protocol is still a surprising thing to invest in. This is because a lot of people are talking about it and many investors are interested, in the Bio Protocol. The Bio Protocol price can change quickly because of this.#BIOProtocol #DeSci #CryptoBreakout
#altcoinseason
The $BIO o Protocol is doing well because some rich people are putting a lot of money into it. This is making more people want to buy the Bio Protocol. The Bio Protocol is also useful for something called Decentralized Science. This is making people want to buy it more.
It is easier to buy and sell the Bio Protocol now because it is available on trading platforms. This is why the Bio Protocol price is changing a lot. If the Bio Protocol price stays above $0.035 it might keep going up. It could even reach $0.040.. If it falls below $0.035 it could go down to $0.032.
The $Bio Protocol is still a surprising thing to invest in. This is because a lot of people are talking about it and many investors are interested, in the Bio Protocol. The Bio Protocol price can change quickly because of this.#BIOProtocol #DeSci #CryptoBreakout
#altcoinseason
𝗕𝗲𝗲𝗻 𝘄𝗮𝘁𝗰𝗵𝗶𝗻𝗴 $𝗕𝗜𝗢 𝗳𝗼𝗿 𝘄𝗲𝗲𝗸𝘀… 𝗻𝗼 𝗼𝗻𝗲’𝘀 𝘁𝗮𝗹𝗸𝗶𝗻𝗴 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 “𝗗𝗲𝗦𝗰𝗶 𝗺𝗼𝗻𝗲𝘆” 𝘀𝗵𝗶𝗳𝘁
Why: wet-lab attestation + autonomous PeptAI pipeline turns hype into measurable execution under the radar at @bioprotocol
The play: load up, window closing soon 🚀 #BioProtocol #DeSci #BIO
Why: wet-lab attestation + autonomous PeptAI pipeline turns hype into measurable execution under the radar at @bioprotocol
The play: load up, window closing soon 🚀 #BioProtocol #DeSci #BIO
$BIO pumped 15% today, and I just cleared my position last week. 😭
Honestly, I've always felt something was 'off' about these AI + DeSci narrative coins—great talks from the project, but every time it spikes, it’s the futures that move first, leaving spot traders with the scraps.
Today's data reflects that.
Futures volume was $41M, while spot only hit $13M, a 3x ratio.
With so many positions stacked in futures, the funding rate is at **-0.4%**, meaning shorts are paying up.
This setup seems a bit strange—shorts are getting hit but aren't bailing; either they truly don’t believe in this rally, or they’re waiting for a higher point to flip.
I tend to think this surge is driven by emotions + pressured shorts, not a real fundamental shift.
$0.0382 was today’s high, and now we’re back around $0.0358, following a typical pump and dump rhythm.
My girlfriend (the full-time trader) sent a message last night: "With a chart like BIO, only noobs chase it."
I’m not holding any position; I choose to trust her.
I won’t chase at this level; it’s too exhausting—better to save my energy for clearer opportunities.
$BIO #BIO #DeSci #FuturesWatch
If I lose, don’t hit me up; if I profit, buy me a coffee.
Honestly, I've always felt something was 'off' about these AI + DeSci narrative coins—great talks from the project, but every time it spikes, it’s the futures that move first, leaving spot traders with the scraps.
Today's data reflects that.
Futures volume was $41M, while spot only hit $13M, a 3x ratio.
With so many positions stacked in futures, the funding rate is at **-0.4%**, meaning shorts are paying up.
This setup seems a bit strange—shorts are getting hit but aren't bailing; either they truly don’t believe in this rally, or they’re waiting for a higher point to flip.
I tend to think this surge is driven by emotions + pressured shorts, not a real fundamental shift.
$0.0382 was today’s high, and now we’re back around $0.0358, following a typical pump and dump rhythm.
My girlfriend (the full-time trader) sent a message last night: "With a chart like BIO, only noobs chase it."
I’m not holding any position; I choose to trust her.
I won’t chase at this level; it’s too exhausting—better to save my energy for clearer opportunities.
$BIO #BIO #DeSci #FuturesWatch
If I lose, don’t hit me up; if I profit, buy me a coffee.
Log in to explore more content